Luigi Mangione, the 28-year-old accused of shooting UnitedHealthcare CEO Brian Thompson dead on a Manhattan sidewalk in December 2024, is expected to plead guilty Friday to federal charges, according to sources familiar with the matter who spoke to NBC News. The expected plea comes less than a month before jury selection was set to begin in his separate state murder case. If the deal holds, it could effectively blow up the state prosecution entirely.
What He's Actually Pleading To
The federal case against Mangione carries two counts of stalking resulting in death. Yes, stalking. That is the charge the federal government landed on for a premeditated killing that involved a cross-country manhunt, a ghost gun, a silencer, and a notebook allegedly detailing the plan to kill Thompson. The Justice Department initially wanted the death penalty, but U.S. District Judge Margaret Garnett blocked that effort back in January.
It is still unclear whether Mangione will plead guilty to one or both of the stalking counts, and NBC News reports that sources close to the matter stressed that nothing is final until Mangione himself enters the plea. He could, technically, walk into that courtroom Friday morning and change his mind entirely. Plea negotiations, per those same sources, are still ongoing as of this writing.
The State Case Just Got Very Complicated
Here is where it gets legally messy in ways that Manhattan District Attorney Alvin Bragg's office probably does not love. NBC News legal analyst Danny Cevallos says that under New York law, a federal guilty plea could bar a subsequent state prosecution for the same conduct. Mangione's defense team has been beating the double jeopardy drum since the very beginning of both cases, and a federal conviction hands them a crowbar.
If Mangione pleads guilty Friday, his lawyers are expected to immediately seek dismissal of some or all of the charges in the state case, where jury selection was scheduled to begin September 8. In that case, Mangione has pleaded not guilty to eight felony charges, including second-degree murder and multiple weapons counts. The Manhattan DA's office, which claimed primary jurisdiction because it charged Mangione first, declined to comment. Make of that silence what you will.
The New York Post reports that the DA's office could still push to take Mangione to trial if it disapproves of the federal plea terms. Whether that actually happens may depend on what kind of deal gets struck Friday and how much of a fight Bragg's office wants to pick with the federal system over a defendant who is, one way or another, facing the rest of his life in prison.
How We Got Here: A Very Brief Recap
In December 2024, Thompson was shot and killed outside the Hilton Hotel in midtown Manhattan, hours before UnitedHealthcare was scheduled to host an investor conference inside the same building. Surveillance footage showed a masked gunman approaching Thompson from behind on the street and opening fire. The footage went viral almost instantly.
What followed was a days-long, multi-state manhunt that, depending on your social media feed at the time, felt either like a grim national emergency or the most riveting true-crime story in years. It ended at a McDonald's in Altoona, Pennsylvania, where Mangione was arrested. Authorities say they found a notebook on him containing what prosecutors describe as plans to kill Thompson. He has attracted supporters to court appearances ever since.
The Folk Hero Problem Nobody Wants to Talk About
NBC News notes, carefully and with appropriate journalistic restraint, that Mangione has "become some sort of folk hero to some." That is a polite way of describing what actually happened, which is that a significant chunk of the American internet treated his arrest like the opening act of a revolution against the health insurance industry. People showed up to his court appearances. He got fan mail. People cited him in unrelated criminal cases.
This is the context in which both the federal government and the Manhattan DA have been trying to prosecute a murder case. The killing of Brian Thompson cracked something open in the national conversation about healthcare costs, claim denials, and the human consequences of an industry built on telling sick people no. That does not make what Mangione is accused of legal, justified, or anything other than killing a person. But it does explain why this case has never felt like a normal murder prosecution, and why a quiet federal plea deal on a Friday in August is not going to close the conversation.
What Happens Next
Mangione is scheduled to appear at a morning hearing in Manhattan federal court Friday, per the New York Post. If he enters the guilty plea as expected, the immediate battlefield shifts to the state case and whether New York's double jeopardy protections effectively take it off the table.
Regardless of how the state case resolves, Mangione still faces the possibility of a life sentence on the federal charges alone. This is not a story with a clean ending. There is no version of Friday where Luigi Mangione walks out of that courtroom a free man. The only real question is whether Manhattan prosecutors get their turn in front of a jury, or whether a federal plea quietly closes the door on the most high-profile murder trial New York has seen in years.
The Dingo Take
You are supposed to believe this is a tidy resolution. A plea deal, a guilty finding, the justice system doing its job. Move along. But a federal stalking charge for a premeditated, surveilled, notebook-documented assassination of a major corporate executive is a genuinely strange legal container for this crime, and the whole thing has the feeling of a system trying to resolve something it never quite knew how to hold.
The Justice Department tried to execute him and got blocked. Now it might get a guilty plea to stalking. The state wanted its trial and might get double jeopardied out of one. The DA's office is staying quiet. The defense, meanwhile, has been playing this exactly right since day one, keeping every possible door open while the federal and state systems occasionally tripped over each other. Whatever you think of Mangione or what he allegedly did, his legal team has run a more coherent strategy than either prosecution.
Brian Thompson is dead. His family has been living inside this case for twenty months. Whatever comes out of that courtroom Friday, the national argument this killing sparked about healthcare, about denial rates, about what it actually costs when a corporation tells someone their treatment is not medically necessary, that argument is not going anywhere. A guilty plea is not a verdict on any of that. It is just the system finding a door it can actually close.
Comments